Display options
Share it on

Immun Ageing. 2012 Oct 31;9(1):23. doi: 10.1186/1742-4933-9-23.

CMV and Immunosenescence: from basics to clinics.

Immunity & ageing : I & A

Rafael Solana, Raquel Tarazona, Allison E Aiello, Arne N Akbar, Victor Appay, Mark Beswick, Jos A Bosch, Carmen Campos, Sara Cantisán, Luka Cicin-Sain, Evelyna Derhovanessian, Sara Ferrando-Martínez, Daniela Frasca, Tamas Fulöp, Sheila Govind, Beatrix Grubeck-Loebenstein, Ann Hill, Mikko Hurme, Florian Kern, Anis Larbi, Miguel López-Botet, Andrea B Maier, Janet E McElhaney, Paul Moss, Elissaveta Naumova, Janko Nikolich-Zugich, Alejandra Pera, Jerrald L Rector, Natalie Riddell, Beatriz Sanchez-Correa, Paolo Sansoni, Delphine Sauce, Rene van Lier, George C Wang, Mark R Wills, Maciej Zieliński, Graham Pawelec

Affiliations

  1. Immunology Unit, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)-Reina Sofia University Hospital-University of Cordoba, Cordoba, Spain. [email protected].

PMID: 23114110 PMCID: PMC3585851 DOI: 10.1186/1742-4933-9-23

Abstract

Alone among herpesviruses, persistent Cytomegalovirus (CMV) markedly alters the numbers and proportions of peripheral immune cells in infected-vs-uninfected people. Because the rate of CMV infection increases with age in most countries, it has been suggested that it drives or at least exacerbates "immunosenescence". This contention remains controversial and was the primary subject of the Third International Workshop on CMV & Immunosenescence which was held in Cordoba, Spain, 15-16th March, 2012. Discussions focused on several main themes including the effects of CMV on adaptive immunity and immunosenescence, characterization of CMV-specific T cells, impact of CMV infection and ageing on innate immunity, and finally, most important, the clinical implications of immunosenescence and CMV infection. Here we summarize the major findings of this workshop.

References

  1. Am J Epidemiol. 2010 Aug 15;172(4):363-71 - PubMed
  2. PLoS One. 2012;7(7):e42403 - PubMed
  3. Sci Transl Med. 2012 Apr 4;4(128):128ra42 - PubMed
  4. PLoS One. 2011 Feb 17;6(2):e16103 - PubMed
  5. Immun Ageing. 2011 Oct 28;8(1):10 - PubMed
  6. Tissue Antigens. 2011 Mar;77(3):187-92 - PubMed
  7. J Exp Med. 2005 Sep 5;202(5):673-85 - PubMed
  8. J Virol. 2012 Jan;86(2):1001-9 - PubMed
  9. Age (Dordr). 2013 Feb;35(1):251-9 - PubMed
  10. Immun Ageing. 2012 Mar 29;9:1 - PubMed
  11. Epidemiol Infect. 2009 Jan;137(1):58-65 - PubMed
  12. Immunol Cell Biol. 2012 Jan;90(1):109-15 - PubMed
  13. J Innate Immun. 2011;3(4):337-43 - PubMed
  14. J Leukoc Biol. 2012 Feb;91(2):197-205 - PubMed
  15. Blood. 2012 Feb 16;119(7):1702-12 - PubMed
  16. Exp Gerontol. 2004 Apr;39(4):607-13 - PubMed
  17. J Immunol Methods. 2010 Jan 31;352(1-2):111-7 - PubMed
  18. PLoS Pathog. 2012;8(8):e1002849 - PubMed
  19. Age (Dordr). 2013 Aug;35(4):1387-99 - PubMed
  20. Immun Ageing. 2010 Sep 07;7:13 - PubMed
  21. J Gerontol A Biol Sci Med Sci. 2013 Jan;68(1):1-5 - PubMed
  22. J Immunol. 2012 Dec 1;189(11):5356-66 - PubMed
  23. Immun Ageing. 2012 Aug 28;9(1):18 - PubMed

Publication Types

Grant support